074430 — AMINOLOGICS CO Cashflow Statement
0.000.00%
- KR₩83bn
- KR₩46bn
- KR₩17bn
Annual cashflow statement for AMINOLOGICS CO, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 2,140 | 5,360 | -7,282 | 2,436 | -1,620 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 471 | -639 | 15,760 | 754 | 3,466 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1,070 | -4,064 | -3,603 | -3,855 | 5,155 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 1,768 | 936 | 5,226 | -218 | 7,466 |
Capital Expenditures | -368 | -662 | -503 | -156 | -512 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -621 | 29.5 | -332 | 0 | 45.8 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -989 | -632 | -835 | -156 | -466 |
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -152 | -164 | -191 | -224 | -227 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 440 | 281 | 3,877 | -740 | 6,884 |